The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...

SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...

Aug. 6, 2002 — Biologic therapies provide safe and effective systemic treatment for psoriasis sufferers, according to presentations at the American Academy of Dermatology's (AAD) Academy 2002 in New ...

The US Food and Drug Administration has approved Sandoz' biosimilar of Amgen's blockbuster Enbrel. The US Food and Drug Administration has approved Sandoz’ biosimilar of Amgen’s blockbuster Enbrel.

Oct. 14, 2004 — The U.S. Food and Drug Administration (FDA) has approved caspofungin acetate for the empiric treatment of presumed fungal infections in the setting of febrile neutropenia, etanercept ...

The needle stays hidden during injection and a sensor can detect placement on skin. It also includes 3 difference injection speeds, a progress bar and a speaker. Amgen announced the availability of ...

Sandoz Group AG (OTC:SDZNY) (OTC:SDZXF) on Monday filed an antitrust lawsuit in the U.S. against Amgen, Inc. (NASDAQ:AMGN) for extending and entrenching the dominant market position of its blockbuster ...

The psoriasis-easing effect of Enbrel, a drug that dampens inflammatory immune responses, lasts for at least two years, a large-scale clinical trial shows. Enbrel acts like a very specific sponge that ...